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Figure S3.
13 C NMR spectrum of compound 1 in CD3OD (600 MHz). . The MDR strains was seeded in LB medium and then incubated at 37 °C for 20 h. After dilution with LB to 10 8 cfu/mL, 25 μL of cell suspension was mixed with 25 mL LB medium for each plate. Subsequently, 10 μL of compound solution (3 mg/mL) were added to the plate wells, and the inhibition zones were observed after incubation at 37 °C for 20 h [5] .
Viabilities of human colon (HT-29) and human breast (MCF-7) cell lines were measured by sulphorhodamine (SRB) assay. Briefly, logarithmically growing cells were trypsinized from culture dishes and placed into 96-well plate. After incubation at 37 °C for 24 h, the compounds were added with varying concentrations. Finally, the SRB was used to stain cells, and the optical density (OD) at 540 nm was measured by a multi-detection microplate reader [6] . The 50% inhibitory concentration (IC50) was determined by using a program GraphPad Prism 5.
